18.69 USD
↘ 0.10 (0.51%)PRE MARKET (AS OF 04:01 AM EDT)
Quince Therapeutics, Inc. Common Stock
QNCXNASDAQ • USD
Market: OPEN
Quince Therapeutics, Inc. Common Stock (QNCX) trades at $18.69 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jul 21, 2026.
Open?$18.74
High?$18.74
Low?$18.74
Prev. Close?$18.78
Volume?14
Avg. Volume?203.9K
VWAP?$18.74
Rel. Volume?0.00x
Bid / Ask
Bid?$15.72 × 100
Ask?$21.65 × 100
Spread?$5.93
Midpoint?$18.69
Valuation & Ratios
Market Cap?18.4M
Shares Out?978.0K
Float?15.3M
Float %?93.7%
P/E Ratio?N/A
P/B Ratio?1.17
EPS?-$36.97
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Employees
38
Market Cap
18.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2019-05-09
Address
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-910-5717
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-910-5717
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?68
Piotroski F-Score?0/9Weak
Altman Z-Score?-27.73Distress
Confidence?44%Low
Short InterestModerate
Short % of Float?0.74%Low
Short Interest?112.8K
Days to Cover?4.8
Free Float15.3M
Avg Daily Volume23.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?2.92Strong
Quick Ratio?2.92Strong
Cash Ratio?2.07Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.17CHEAP▾
Peers100
S&P94
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-230.7%WEAK▾
S&P3
ROA?-135.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-37731000
Enterprise Value?$203.1K
Fundamentals ratios updated end of day